Price $4.07 |
Market Cap
22.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.85
|
P/S
0.77
|
Dividend %
-
|
|
P/CF
1.0
|
P/FCF
-
|
Op. Cash Flow
-42.2K
|
FCF
-1.5
|
|
Op. Margin
-124.40%
|
Net Margin
-128.10%
|
ROE
-97.00%
|
ROI
-71.10%
|
|
ROA
-42.70%
|
EPS Growth
21.50%
|
Current Ratio
4.1
|
Debt/Equity
42.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
